Abstract
In this study, the crystallization by anti-solvent and sonocrystallization were used for recrystallization of the cinnamic acid (CA), in order to evaluate the influence of these techniques on the modification of the solid-state properties and the aqueous solubility of the CA, since this has low aqueous solubility. The obtained crystals were characterized by differential scanning calorimetry (DSC), differential thermal analysis (DTA), thermogravimetry (TG), powder X-ray diffraction, Fourier transform infrared spectrophotometry (FTIR) and scanning electron microscope (SEM). The effect of recrystallization was also evaluated by particle size and saturation solubility study. In general, the results showed that by the DSC, DTA and TG techniques, the thermal profile of the CA was not altered, as there were no chemical changes in the structure of the CA for the FTIR data, nor any major changes in the crystalline pattern of CA, only some differences in peak intensity. For the analyses of SEM and particle size, a more regular shape and a more even distribution of crystal size were observed after the crystallization process. A slight increase in CA solubility was observed when the solvents methanol and acetic acid were used. Therefore, it is possible to infer that the crystallization techniques used have given modifications in the properties of the solid state that can contribute to the improvement of technological characteristics of the powder favoring the use of CA in several pharmaceutical formulations.
Similar content being viewed by others
References
Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 2007;59:617–30.
Dhumal RS, Biradar SV, Paradkar AR, York P. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery. Int J Pharm. 2009;368:129–37.
Belkacem N, Salem MAS, Alkhatib HS. Effect of ultrasound on the physico-chemical properties of poorly soluble drugs: antisolvent sonocrystallization of ketoprofen. Powder Technol. 2015;285:16–24.
Variankaval N, Cote AS. From form to function: crystallization of active pharmaceutical ingredients. AIChE J. 2008;54:1682–8.
Su CS, Wu PY, Jheng WD. Recrystallization of phenacetin and sulfathiazole using the sonocrystallization process. J Taiwan Inst Chem Eng. 2016;59:106–12.
Guo Z, Zhang M, Li H, Wang J, Kougoulos E. Effect of ultrasound on anti-solvent crystallization process. J Cryst Growth. 2005;273:555–63.
Kougoulos E, Marziano I, Miller PR. Lactose particle engineering: influence of ultrasound and anti-solvent on crystal habit and particle size. J Cryst Growth. 2010;312:3509–20.
Verma S, Gokhale R, Burgess DJ. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009;380:216–22.
Thorat AA, Dalvi SV. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective. Chem Eng J. 2012;181–182:1–34.
Sun X, Garetz BA, Myerson AS. Supersaturation and polarization dependence of polymorph control in the nonphotochemical laser-induced nucleation (NPLIN) of aqueous glycine solutions. Cryst Growth Des. 2006;6:684–9.
Muhammad SAFAS, Oubani H, Abbas A, Chan HK, Kwok PCL, Dehghani F. The production of dry powder by the sonocrystallisation for inhalation drug delivery. Powder Technol. 2013;246:337–44.
Wu HT, Yang MW, Huang SC. Sub-micrometric polymer particles formation by a supercritical assisted atomization process. J Taiwan Inst Chem Eng. 2014;45:1992–2001.
Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB. Solid-state characterization and issolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm. 2007;67:531–9.
Lyra MAM, Alves LDS, Fontes DAF, Soares Sobrinho JL, Rolim Neto PJ. Ferramentas analíticas aplicadas à caracterização de complexos de inclusão fármaco—ciclodextrina. Rev Ciênc Farm Básica Apl. 2010;31:117–24.
Soares Sobrinho JL, Soares MFLR, Rolim Neto PJ, Labandeira JJT. Physicochemical study of solid state benznidazole cyclodextrin complexes. J Therm Anal Calorim. 2010;10:10973.
Soares Sobrinho JL, Soares MFLR, Alves LDS, Labandeira JJT, Rolim Neto PJ. Improving the solubility of the antichagasic drug benznidazole through formation of inclusion complex. Quim Nova. 2011;34:1534–8.
Brittain HG. Characterization of pharmaceutical compounds in the solid state. 2nd ed. Amsterdam: Elsevier Inc.; 2011. p. 11–58.
Madhurambal G, Ravindran B, Mariappan M, Ramamurthi K, Mojumdar SC. Growth and characterization of cinnamic acid–urea single crystal. J Therm Anal Calorim. 2011;104:875–8.
Souza CMP, Santos JAB, Nascimento AL, Júnior JVC, Júnior FJDLR, Lima Neto SA, Souza FS, Macêdo RO. Thermal analysis study of solid dispersions hydrochlorothiazide. J Therm Anal Calorim. 2018;131:681–9.
Júnior FJDLR, et al. Investigation of the thermal behavior of inclusion complexes with antifungal activity. J Therm Anal Calorim. 2018;133:641–8.
Marques V, Farah A. Chlorogenic acids and related compounds in medicinal plants and infusions. Food Chem. 2009;113:1370–6.
Liu L, et al. Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer. 1995;62:345–50.
Murakami FS, et al. Comparative behavior studies of cinnamic acid using isothermal and nonisothermal kinetic methods. Pharm Chem J. 2009;43:716–20.
Yen GC, Chen YL, Sun FM, Chiang YL, Lu SH, Weng CJ. A comparative study on the effectiveness of cis-and trans-form of cinnamic acid treatments for inhibiting invasive activity of human lung adenocarcinoma cells. Eur J Pharm Sci. 2011;44:281–7.
Jung EH, Kim SR, Hwang IK, Ha TY. Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J Agric Food Chem. 2007;55:9800–4.
Adisakwattana S, Moonsan P, Yibchok-Anun S. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem. 2008;56:7838–44.
Sharma P. Cinnamic acid derivatives: a new chapter of various pharmacological activities. J Chem Pharm Res. 2011;3:403–23.
Yang C, Zhou Y, Zheng Y, Li C, Sheng S, Wang J, Wu F. Enzymatic modification of chitosan by cinnamic acids: antibacterial activity against Ralstonia solanacearum. Int J Biol Macromol. 2016;87:577–85.
Garcia-Jimenez A, et al. Catalysis and inhibition of tyrosinase in the presence of cinnamic acid and some of its derivatives. Int J Biol Macromol. 2018;119:548–54.
Medham J, Denney RC, Barnes JD, Thomas M. Análise química quantitativa. 6th ed. Rio de Janeiro: Livros Técnicos e Científicos Editora AS; 2002. p. 265–76.
Higuchi TK, Connors A. Phase-solubility techniques. 1965.
Shayanfar A, Asadpour-Zeynali K, Jouyban A. Solubility and dissolution rate of a carbamazepine–cinnamic acid cocrystal. J Mol Liq. 2013;187:171–6.
Li W, Zhao X, Sun X, Zu Y, Liu Y, Ge Y. Evaluation of antioxidant ability in vitro and bioavailability of trans-cinnamic acid nanoparticle by liquid antisolvent precipitate. J Nanomater. 2016;2016:84.
Hanai K, Kuwae A, Takai T, Senda H, Kunimoto KK. A comparative vibrational and NMR study of cis-cinnamic acid polymorphs and trans-cinnamic acid. Spectrochim Acta A Mol Biomol Spectrosc. 2001;57:513–9.
Kalinowska M, Świsłocka R, Lewandowski W. The spectroscopic (FT-IR, FT-Raman and 1 H, 13 C NMR) and theoretical studies of cinnamic acid and alkali metal cinnamates. J Mol Struct. 2007;834:572–80.
Vinod KS, Periandy S, Govindarajan M. Spectroscopic analysis of cinnamic acid using quantum chemical calculations. Spectrochim Acta A Mol Biomol Spectrosc. 2015;136:808–17.
USP 30. The United States pharmacopeia. 30th ed. Rockville: US Pharmacopeial Convention Inc.; 2007.
Bogdashev NN, Mykots LP, Simonyan AV. Physicochemical characterization of cinnamic acid derivatives. Part 2. Calculation of the temperature of melting and enthalpy of formation by the method of structural analogy. Pharm Chem J. 1998;32:145–8.
Nemen D, Lemos-Senna E. Preparação e caracterização de suspensões coloidais de nanocarreadores lipídicos contendo resveratrol destinados à administração cutânea. Quim Nova. 2011;34:408–13.
Souza PMS, Lobo FA, Rosa AH, Fraceto LF. Desenvolvimento de nanocápsulas de poli-e-caprolactona contendo o herbicida atrazina. Quim Nova. 2012;35:132–7.
Shekunov BY, York P. Crystallization processes in pharmaceutical technology and drug delivery design. J Cryst Growth. 2000;211:122–36.
Chen J, Sarma B, Evans JM, Myerson AS. Pharmaceutical crystallization. Cryst Growth Des. 2011;11:887–95.
Mota FL, Queimada AJ, Pinho SP, Macedo EA. Aqueous solubility of some natural phenolic compounds. Ind Eng Chem Res. 2008;47:5182–9.
Strazišar M, Andrenšek S, Šmidovnik A. Effect of b-cyclodextrin on antioxidant activity of coumaric acids. Food Chem. 2008;110:636–42.
Liu B, Zeng J, Chen C, Liu Y, Ma H, Mo H, Liang G. Interaction of cinnamic acid derivatives with β-cyclodextrin in water: experimental and molecular modeling studies. Food Chem. 2016;194:1156–63.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Batista, R.S.d., Melo, T.B.L., dos Santos, J.A.B. et al. Evaluation of crystallization technique relating to the physicochemical properties of cinnamic acid. J Therm Anal Calorim 138, 3727–3735 (2019). https://doi.org/10.1007/s10973-019-08455-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-019-08455-7